| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j0610G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0100610 |
| P932 | PMC publication ID | 4105653 |
| P698 | PubMed publication ID | 25047038 |
| P5875 | ResearchGate publication ID | 264127281 |
| P50 | author | Stewart McCallum | Q57039386 |
| Rachel A Gibson | Q57700532 | ||
| P2093 | author name string | Gil Yosipovitch | |
| Disala Fernando | |||
| Jon Robertson | |||
| Melody Wyres | |||
| Harshna Mistry | |||
| P2860 | cites work | TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. | Q52608362 |
| Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases. | Q53381596 | ||
| Antipruritic Effects of TRPV1 Antagonist in Murine Atopic Dermatitis and Itching Models | Q58390465 | ||
| TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase | Q79847967 | ||
| Scratching the surface: a role of pain-sensing TRPA1 in itch | Q83975450 | ||
| Effect of mucosal TRPV1 inhibition in allergic rhinitis | Q84996996 | ||
| Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors | Q24654106 | ||
| The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans | Q28238213 | ||
| TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms | Q30488724 | ||
| Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons | Q30540969 | ||
| Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. | Q33290606 | ||
| Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch | Q33851774 | ||
| Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease | Q36742184 | ||
| Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. | Q36753567 | ||
| TRP channels as novel players in the pathogenesis and therapy of itch | Q36803162 | ||
| Histamine 50-skin-prick test: a tool to diagnose histamine intolerance | Q36857443 | ||
| Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig. | Q36929439 | ||
| What causes itch in atopic dermatitis? | Q37208966 | ||
| Therapy of pruritus | Q37738911 | ||
| Urticaria and its subtypes: the role of second-generation antihistamines | Q37966254 | ||
| Transient receptor potential channels and dermatological disorders | Q38083732 | ||
| Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor | Q40152909 | ||
| Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. | Q43677197 | ||
| Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. | Q44516252 | ||
| Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. | Q44885100 | ||
| Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R). | Q46396095 | ||
| The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis | Q48710475 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e100610 | |
| P577 | publication date | 2014-07-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers | |
| P478 | volume | 9 |
| Q38656850 | Advances in therapeutic strategies for the treatment of pruritus |
| Q30655924 | Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates. |
| Q92127855 | Emerging Perspectives on Pain Management by Modulation of TRP Channels and ANO1 |
| Q60606792 | Histaminergic and non-histaminergic elicited itch is attenuated in capsaicin-evoked areas of allodynia and hyperalgesia: A healthy volunteer study |
| Q39429573 | Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments |
| Q38452688 | Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? |
| Q39038882 | Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists |
| Q50185066 | Non-opioid analgesic use and concerns for impaired organ protection. |
| Q48339961 | Regulation of Pain and Itch by TRP Channels |
| Q91694412 | Role of Chemosensory TRP Channels in Lung Cancer |
| Q47176855 | Sensing the heat with TRPM3. |
| Q64956089 | Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis. |
| Q48193824 | Sildenafil Treatment Eliminates Pruritogenesis and Thermal Hyperalgesia in Rats with Portacaval Shunts. |
| Q57297139 | TRP Channels as Drug Targets to Relieve Itch |
| Q26739979 | TRPV1 and TRPM8 in Treatment of Chronic Cough |
| Q39090248 | The nervous system of airways and its remodeling in inflammatory lung diseases |
| Q35560404 | TriCalm(®) hydrogel is significantly superior to 2% diphenhydramine and 1% hydrocortisone in reducing the peak intensity, duration, and overall magnitude of cowhage-induced itch |
| Q36703535 | Trp channels and itch |
Search more.